Holiferm is bringing biosurfactants to market and is in the process of building a ktonne scale sophorolipid manufacturing plant.
Holiferm has raised €24M across 2 funding rounds from 3 investors, most recently a Series B round in Jan 2024. Based in Manchester, UK; active in Cleantech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-01-08 | Series B | €21M | Clean Growth Fund,Rhapsody Venture Partners | View deal → |
| 2023-07-28 | Other | €2.3M | Greater Manchester Combined Authority (GMCA) | View deal → |
